| Field | Row 1 |
|---|---|
| adsh | 0001062822-25-000029 |
| cik | 1062822 |
| name | LEXICON PHARMACEUTICALS, INC. |
| sic | 2834 |
| countryba | US |
| stprba | TX |
| cityba | THE WOODLANDS |
| zipba | 77381 |
| bas1 | 2445 TECHNOLOGY FOREST BLVD. |
| bas2 | SUITE 1100 |
| baph | 2818633000 |
| countryma | US |
| stprma | TX |
| cityma | THE WOODLANDS |
| zipma | 77381 |
| mas1 | 2445 TECHNOLOGY FOREST BLVD. |
| mas2 | SUITE 1100 |
| countryinc | US |
| stprinc | DE |
| ein | 760474169 |
| former | LEXICON PHARMACEUTICALS, INC./DE |
| changed | 20070426 |
| afs | 4-NON |
| wksi | 0 |
| fye | 1231 |
| form | 10-Q |
| period | 20250331 |
| fy | 2025 |
| fp | Q1 |
| filed | 20250514 |
| accepted | 2025-05-14 07:09:00.0 |
| prevrpt | 0 |
| detail | 1 |
| instance | lxrx-20250331_htm.xml |
| nciks | 1 |
| aciks |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| cik | Central Index Key (CIK). Ten digit number assigned by the SEC to each registrant that submits filings. |
| name | Name of registrant. This corresponds to the name of the legal entity as recorded in EDGAR as of the filing date. |
| sic | Standard Industrial Classification (SIC). Four digit code assigned by the SEC as of the filing date, indicating the registrant’s type of business. |
| countryba | The ISO 3166-1 country of the registrant's business address. |
| stprba | The state or province of the registrant’s business address, if field countryba is US or CA. |
| cityba | The city of the registrant's business address. |
| zipba | The zip code of the registrant’s business address. |
| bas1 | The first line of the street of the registrant’s business address. |
| bas2 | The second line of the street of the registrant’s business address. |
| baph | The phone number of the registrant’s business address. |
| countryma | The ISO 3166-1 country of the registrant's mailing address. |
| stprma | The state or province of the registrant’s mailing address, if field countryma is US or CA. |
| cityma | The city of the registrant's mailing address. |
| zipma | The zip code of the registrant’s mailing address. |
| mas1 | The first line of the street of the registrant’s mailing address. |
| mas2 | The second line of the street of the registrant’s mailing address. |
| countryinc | The ISO 3166-1 country of incorporation for the registrant. |
| stprinc | The state or province of incorporation for the registrant, if countryinc is US or CA. |
| ein | Employee Identification Number, 9 digit identification number assigned by the Internal Revenue Service to business entities operating in the United States. |
| former | Most recent former name of the registrant, if any. |
| changed | Date of change from the former name, if any. |
| afs | Filer status with the SEC at the time of submission: 1-LAF=Large Accelerated, 2-ACC=Accelerated, 3-SRA=Smaller Reporting Accelerated, 4-NON=Non-Accelerated, 5-SML=Smaller Reporting Filer, NULL=not assigned. |
| wksi | Well Known Seasoned Issuer (WKSI). An issuer that meets specific SEC requirements at some point during a 60-day period preceding the date the issuer satisfies its obligation to update its shelf registration statement. |
| fye | Fiscal Year End Date, rounded to nearest month-end. |
| form | The submission type of the registrant’s filing. |
| period | Balance Sheet Date, rounded to nearest month-end. |
| fy | Fiscal Year Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8). |
| fp | Fiscal Period Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8) within Fiscal Year. |
| filed | The date of the registrant’s filing with the Commission. |
| accepted | The acceptance date and time of the registrant’s filing with the Commission. |
| prevrpt | Previous Report – TRUE indicates that the submission information was subsequently amended. |
| detail | TRUE indicates that the XBRL submission contains quantitative disclosures within the footnotes and schedules at the required detail level (e.g., each amount). |
| instance | The name of the submitted XBRL Instance Document. The name often begins with the company ticker symbol. |
| nciks | Number of Central Index Keys (CIK) of registrants (i.e., business units) included in the consolidating entity’s submitted filing. |
| aciks | Additional CIKs of co-registrants included in a consolidating entity’s EDGAR submission, separated by spaces. If there are no other co-registrants (i.e., nciks=1), the value of aciks is NULL. For a very small number of filers, the entire list of co-registrants is too long to fit in the field. Where this is the case, users should refer to the complete submission file for all CIK information. |
| adsh | ddate | tag | value | uom | qtrs | version | segments | coreg | footnote |
|---|---|---|---|---|---|---|---|---|---|
| 0001062822-25-000029 | 20241231 | Accounts Payable Current | 14801000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20241231 | Accrued Liabilities Current | 30447000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20250331 | Additional Paid In Capital | 2120365000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20231231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 22465000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 62888000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20240331 | Common Stock Shares Issued | 247765000.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001062822-25-000029 | 20241231 | Common Stock Shares Issued | 363020000.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001062822-25-000029 | 20250331 | Common Stock Shares Issued | 365560000.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001062822-25-000029 | 20250331 | Depreciation Depletion And Amortization | 176000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20250331 | Increase Decrease In Inventories | -30000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20240331 | Interest Paid Net | 3257000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20250331 | Interest Paid Net | 2968000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20250331 | Liabilities | 174639000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20241231 | Liabilities And Stockholders Equity | 298420000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20250331 | Other Assets Noncurrent | 368000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20240331 | Other Expenses | 4948000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Reportable Segment; | ||
| 0001062822-25-000029 | 20250331 | Other Nonoperating Income Expense | 2219000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20240331 | Preferred Stock Shares Issued | 2304000.0000 | shares | 0 | us-gaap/2024 | Equity Components= Preferred Stock; | ||
| 0001062822-25-000029 | 20250331 | Preferred Stock Shares Issued | 0.0000 | shares | 0 | us-gaap/2024 | Equity Components= Preferred Stock; | ||
| 0001062822-25-000029 | 20250331 | Research And Development Expense | 13609000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Reportable Segment; | ||
| 0001062822-25-000029 | 20240331 | Revenue From Contract With Customer Excluding Assessed Tax | 1093000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Reportable Segment; | ||
| 0001062822-25-000029 | 20240331 | Royalty Income Nonoperating | 37000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Reportable Segment; | ||
| 0001062822-25-000029 | 20250331 | Share Based Compensation | 1469000.0000 | USD | 1 | us-gaap/2024 | Nature Of Expense= Selling General And Administrative Expenses; | ||
| 0001062822-25-000029 | 20240331 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | -50000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001062822-25-000029 | 20240331 | Stock Issued During Period Value New Issues | 241552000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001062822-25-000029 | 20240331 | Stock Issued During Period Value Share Based Compensation Gross | 3000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001062822-25-000029 | 20241231 | Treasury Stock Value | 4615000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20240331 | Accretion Amortization Of Discounts And Premiums Investments | 1399000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20240331 | Adjustments Related To Tax Withholding For Share Based Compensation | 1730000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Treasury Stock Common; | ||
| 0001062822-25-000029 | 20240331 | Amortization Of Financing Costs And Discounts | 517000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20250331 | Amortization Of Financing Costs And Discounts | 401000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20241231 | Assets Current | 246193000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -3768000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20241231 | Commitments And Contingencies | USD | 0 | us-gaap/2024 | ||||
| 0001062822-25-000029 | 20250331 | Common Stock Shares Issued | 365559939.0000 | shares | 0 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20250331 | Cost Of Goods And Services Sold | 30000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20241231 | Goodwill | 44543000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20250331 | Net Cash Provided By Used In Financing Activities | -572000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20241231 | Other Assets Noncurrent | 368000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20250331 | Other Expenses | 1835000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Reportable Segment; | ||
| 0001062822-25-000029 | 20240331 | Other Noncash Income Expense | -1173000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20240331 | Other Nonoperating Income Expense | 1884000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Reportable Segment; | ||
| 0001062822-25-000029 | 20250331 | Payments To Acquire Investments | 64971000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20241231 | Preferred Stock Shares Issued | 0.0000 | shares | 0 | us-gaap/2024 | Equity Components= Preferred Stock; | ||
| 0001062822-25-000029 | 20240331 | Research And Development Expense | 12777000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Reportable Segment; | ||
| 0001062822-25-000029 | 20250331 | Revenue From Contract With Customer Excluding Assessed Tax | 1262000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20250331 | Royalty Income Nonoperating | 0.0000 | USD | 1 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20231231 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 1862558000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001062822-25-000029 | 20240331 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | -4615000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Treasury Stock Common; | ||
| 0001062822-25-000029 | 20241231 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 119000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001062822-25-000029 | 20241231 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | -1967242000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001062822-25-000029 | 20241231 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | -4615000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Treasury Stock Common; | ||
| 0001062822-25-000029 | 20240331 | Weighted Average Number Of Diluted Shares Outstanding | 245390000.0000 | shares | 1 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20240331 | Weighted Average Number Of Shares Outstanding Basic | 245390000.0000 | shares | 1 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20240331 | Operating Income Loss | -45333000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20241231 | Accounts Receivable Net Current | 3473000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20250331 | Accounts Receivable Net Current | 47447000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20250331 | Accounts Receivable Net Current | 45.0000 | USD | 0 | us-gaap/2024 | Counterparty Name= Novo Nordisk; Product Or Service= License; | ||
| 0001062822-25-000029 | 20250331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 3043000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20250331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 3043000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001062822-25-000029 | 20241231 | Cash And Cash Equivalents At Carrying Value | 66656000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20250331 | Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction | 0.0000 | USD | 1 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20240331 | Earnings Per Share Diluted | -0.2000 | USD | 1 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20250331 | Earnings Per Share Diluted | -0.0700 | USD | 1 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20250331 | Increase Decrease In Accounts Receivable | -1026000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20240331 | Increase Decrease In Inventories | 133000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20250331 | Increase Decrease In Other Operating Assets | -186000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20250331 | Liabilities Current | 110693000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20240331 | Operating Income Loss | -45333000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Reportable Segment; | ||
| 0001062822-25-000029 | 20250331 | Operating Income Loss | -25679000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20241231 | Other Assets Current | 4532000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20240331 | Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax | -81000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20240331 | Other Expenses | 4948000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20241231 | Preferred Stock Value | 0.0000 | USD | 0 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20250331 | Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options | 0.0000 | USD | 1 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20250331 | Property Plant And Equipment Net | 2308000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20250331 | Revenue From Contract With Customer Excluding Assessed Tax | 1262000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Reportable Segment; | ||
| 0001062822-25-000029 | 20240331 | Share Based Compensation | 1594000.0000 | USD | 1 | us-gaap/2024 | Nature Of Expense= Research And Development Expense; | ||
| 0001062822-25-000029 | 20241231 | Stockholders Equity | 145950000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20231231 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | -2885000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Treasury Stock Common; | ||
| 0001062822-25-000029 | 20240331 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 23000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Preferred Stock; | ||
| 0001062822-25-000029 | 20250331 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 25000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001062822-25-000029 | 20240331 | Stock Issued During Period Value Share Based Compensation Gross | 85000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001062822-25-000029 | 20241231 | Treasury Stock Common Shares | 1528008.0000 | shares | 0 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20250331 | Goodwill | 44543000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20250331 | Accrued Liabilities Current | 12948000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20250331 | Accumulated Other Comprehensive Income Loss Net Of Tax | 25000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20241231 | Assets | 298420000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20250331 | Assets | 297671000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20240331 | Common Stock Shares Authorized | 450000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20250331 | Common Stock Shares Authorized | 450000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20250331 | Common Stock Value | 366000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20240331 | Comprehensive Income Net Of Tax | -48478000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20240331 | Cost Of Goods And Services Sold | 31000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20250331 | Cost Of Goods And Services Sold | 30000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Reportable Segment; | ||
| 0001062822-25-000029 | 20240331 | Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction | 150000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20250331 | Earnings Per Share Basic | -0.0700 | USD | 1 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20240331 | Increase Decrease In Prepaid Deferred Expense And Other Assets | 1879000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20241231 | Long Term Debt Current | 0.0000 | USD | 0 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20250331 | Long Term Debt Current | 42056000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20240331 | Net Cash Provided By Used In Operating Activities | -55130000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20240331 | Net Income Loss | -48397000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001062822-25-000029 | 20250331 | Operating Income Loss | -25679000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Reportable Segment; | ||
| 0001062822-25-000029 | 20240331 | Payments To Acquire Investments | 183224000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20241231 | Preferred Stock Par Or Stated Value Per Share | 0.0100 | USD | 0 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20250331 | Preferred Stock Shares Authorized | 5000000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20241231 | Preferred Stock Shares Issued | 2304147.0000 | shares | 0 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20241231 | Preferred Stock Shares Outstanding | 0.0000 | shares | 0 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20250331 | Proceeds From Sale Maturity And Collections Of Investments | 105553000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20240331 | Share Based Compensation | 4302000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20240331 | Share Based Compensation | 2708000.0000 | USD | 1 | us-gaap/2024 | Nature Of Expense= Selling General And Administrative Expenses; | ||
| 0001062822-25-000029 | 20250331 | Share Based Compensation | 1574000.0000 | USD | 1 | us-gaap/2024 | Nature Of Expense= Research And Development Expense; | ||
| 0001062822-25-000029 | 20240331 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | -1815236000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001062822-25-000029 | 20250331 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 2120365000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001062822-25-000029 | 20250331 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 366000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001062822-25-000029 | 20250331 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 0.0000 | USD | 0 | us-gaap/2024 | Equity Components= Preferred Stock; | ||
| 0001062822-25-000029 | 20240331 | Stock Issued During Period Shares New Issues | 2304000.0000 | shares | 1 | us-gaap/2024 | Equity Components= Preferred Stock; | ||
| 0001062822-25-000029 | 20240331 | Stock Issued During Period Value New Issues | 23000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Preferred Stock; | ||
| 0001062822-25-000029 | 20250331 | Stock Issued During Period Value Share Based Compensation Gross | 0.0000 | USD | 1 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20250331 | Stock Issued During Period Value Share Based Compensation Gross | -3000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001062822-25-000029 | 20250331 | Treasury Stock Value | 5187000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20250331 | Weighted Average Number Of Diluted Shares Outstanding | 362073000.0000 | shares | 1 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20250331 | Weighted Average Number Of Shares Outstanding Basic | 362073000.0000 | shares | 1 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20250331 | Accretion Amortization Of Discounts And Premiums Investments | 1326000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20241231 | Accumulated Other Comprehensive Income Loss Net Of Tax | 119000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20241231 | Additional Paid In Capital | 2117325000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20250331 | Assets Current | 245806000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20250331 | Cash And Cash Equivalents At Carrying Value | 62888000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 96494000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | 74029000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20240229 | Common Stock Shares Authorized | 300000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20241231 | Contract With Customer Liability | 0.0000 | USD | 0 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20250331 | Contract With Customer Liability | 45.0000 | USD | 0 | us-gaap/2024 | Counterparty Name= Novo Nordisk; Product Or Service= License; | ||
| 0001062822-25-000029 | 20240331 | Costs And Expenses | 46463000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20240331 | Increase Decrease In Accounts Payable And Accrued Liabilities | -9108000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20241231 | Inventory Net | 231000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20250331 | Inventory Net | 201000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20241231 | Liabilities | 152470000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20241231 | Liabilities Current | 45248000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20241231 | Long Term Debt Noncurrent | 100298000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20250331 | Long Term Debt Noncurrent | 58643000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20250331 | Net Cash Provided By Used In Operating Activities | -43778000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20250331 | Net Income Loss | -25295000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20250331 | Net Income Loss | -25295000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Reportable Segment; | ||
| 0001062822-25-000029 | 20250331 | Other Assets Current | 3319000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20240331 | Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax | -81000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001062822-25-000029 | 20250331 | Other Nonoperating Income Expense | 2219000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Reportable Segment; | ||
| 0001062822-25-000029 | 20250331 | Payments Related To Tax Withholding For Share Based Compensation | 572000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20241231 | Preferred Stock Shares Authorized | 5000000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20231231 | Preferred Stock Shares Issued | 0.0000 | shares | 0 | us-gaap/2024 | Equity Components= Preferred Stock; | ||
| 0001062822-25-000029 | 20250331 | Preferred Stock Shares Outstanding | 0.0000 | shares | 0 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20240331 | Proceeds From Issuance Of Convertible Preferred Stock | 241425000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20240331 | Research And Development Expense | 14372000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20240331 | Revenues | 1130000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20250331 | Revenues | 1262000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20240331 | Royalty Income Nonoperating | 37000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20240331 | Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period | 1972000.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001062822-25-000029 | 20250331 | Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period | 2540000.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001062822-25-000029 | 20241231 | Short Term Investments | 171301000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20250331 | Stockholders Equity | 123032000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20231231 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 245000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001062822-25-000029 | 20240331 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 2108497000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001062822-25-000029 | 20241231 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 2117325000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001062822-25-000029 | 20241231 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 363000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001062822-25-000029 | 20250331 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | -5187000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Treasury Stock Common; | ||
| 0001062822-25-000029 | 20250331 | Treasury Stock Common Shares | 2381939.0000 | shares | 0 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20250331 | Accounts Payable Current | 10689000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20240331 | Adjustments Related To Tax Withholding For Share Based Compensation | 1730000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20250331 | Adjustments Related To Tax Withholding For Share Based Compensation | 572000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Treasury Stock Common; | ||
| 0001062822-25-000029 | 20241231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 66656000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20250331 | Common Stock Par Or Stated Value Per Share | 0.0010 | USD | 0 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20241231 | Common Stock Shares Issued | 363020303.0000 | shares | 0 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20240331 | Depreciation Depletion And Amortization | 144000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20240331 | Earnings Per Share Basic | -0.2000 | USD | 1 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20250331 | Net Cash Provided By Used In Investing Activities | 40582000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20240331 | Net Income Loss | -48397000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20240331 | Net Income Loss | -48397000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Reportable Segment; | ||
| 0001062822-25-000029 | 20250331 | Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax | -94000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20250331 | Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax | -94000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001062822-25-000029 | 20240331 | Preferred Stock Par Or Stated Value Per Share | 0.0100 | USD | 0 | us-gaap/2024 | Class Of Stock= Series A Preferred Stock; Subsidiary Sale Of Stock= Private Placement; | ||
| 0001062822-25-000029 | 20241231 | Property Plant And Equipment Net | 2484000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20250331 | Research And Development Expense | 15303000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20250331 | Revenues | 1262000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Reportable Segment; | ||
| 0001062822-25-000029 | 20240331 | Selling General And Administrative Expense | 32060000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20231231 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 93110000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20231231 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 31000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001062822-25-000029 | 20231231 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 0.0000 | USD | 0 | us-gaap/2024 | Equity Components= Preferred Stock; | ||
| 0001062822-25-000029 | 20231231 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | -1766839000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001062822-25-000029 | 20240331 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 248000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001062822-25-000029 | 20241231 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 145950000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20241231 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 0.0000 | USD | 0 | us-gaap/2024 | Equity Components= Preferred Stock; | ||
| 0001062822-25-000029 | 20250331 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | -1992537000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001062822-25-000029 | 20250331 | Stock Issued During Period Value Share Based Compensation Gross | 3000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001062822-25-000029 | 20240331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 4302000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20240331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 4302000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001062822-25-000029 | 20250331 | Commitments And Contingencies | USD | 0 | us-gaap/2024 | ||||
| 0001062822-25-000029 | 20241231 | Common Stock Shares Authorized | 450000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20231231 | Common Stock Shares Issued | 245793000.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001062822-25-000029 | 20241231 | Common Stock Value | 363000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20250331 | Comprehensive Income Net Of Tax | -25389000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20250331 | Costs And Expenses | 26941000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20250331 | Increase Decrease In Accounts Payable And Accrued Liabilities | -21692000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20240331 | Increase Decrease In Accounts Receivable | 516000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20240331 | Increase Decrease In Other Operating Assets | -166000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20250331 | Increase Decrease In Prepaid Deferred Expense And Other Assets | -1213000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20250331 | Liabilities And Stockholders Equity | 297671000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20250331 | Long Term Debt Current | 42100000.0000 | USD | 0 | us-gaap/2024 | Credit Facility= Secured Debt; Debt Instrument= Oxford Finance L L C Term Loans; Longterm Debt Type= Line Of Credit; | ||
| 0001062822-25-000029 | 20240331 | Net Cash Provided By Used In Investing Activities | -110224000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20250331 | Other Expenses | 1835000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20241231 | Other Liabilities Noncurrent | 6924000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20240331 | Other Nonoperating Income Expense | 1884000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20240331 | Payments Related To Tax Withholding For Share Based Compensation | 1730000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20250331 | Preferred Stock Value | 0.0000 | USD | 0 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20250331 | Proceeds From Issuance Of Convertible Preferred Stock | 0.0000 | USD | 1 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20240331 | Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options | 88000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20240331 | Proceeds From Payments For Other Financing Activities | -400000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20241231 | Retained Earnings Accumulated Deficit | -1967242000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20240331 | Revenue From Contract With Customer Excluding Assessed Tax | 1093000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20240331 | Revenues | 1130000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Reportable Segment; | ||
| 0001062822-25-000029 | 20250331 | Royalty Income Nonoperating | 0.0000 | USD | 1 | us-gaap/2024 | Business Segments= Reportable Segment; | ||
| 0001062822-25-000029 | 20250331 | Selling General And Administrative Expense | 11608000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20250331 | Share Based Compensation | 3043000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20240331 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 288867000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20250331 | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 123032000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20240331 | Stock Issued During Period Value New Issues | 241575000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20240331 | Stock Issued During Period Value Share Based Compensation Gross | 88000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20250331 | Preferred Stock Shares Issued | 2304147.0000 | shares | 0 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20250331 | Adjustments Related To Tax Withholding For Share Based Compensation | 572000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20241231 | Common Stock Par Or Stated Value Per Share | 0.0010 | USD | 0 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20250331 | Contract With Customer Liability | 45000000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20240331 | Cost Of Goods And Services Sold | 31000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Reportable Segment; | ||
| 0001062822-25-000029 | 20240331 | Costs And Expenses | 46463000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Reportable Segment; | ||
| 0001062822-25-000029 | 20250331 | Costs And Expenses | 26941000.0000 | USD | 1 | us-gaap/2024 | Business Segments= Reportable Segment; | ||
| 0001062822-25-000029 | 20240331 | Net Cash Provided By Used In Financing Activities | 239383000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20250331 | Net Income Loss | -25295000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001062822-25-000029 | 20241231 | Operating Lease Right Of Use Asset | 4832000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20250331 | Operating Lease Right Of Use Asset | 4646000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20250331 | Other Liabilities Noncurrent | 5303000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20250331 | Other Noncash Income Expense | 1540000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20250331 | Preferred Stock Par Or Stated Value Per Share | 0.0100 | USD | 0 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20250331 | Proceeds From Payments For Other Financing Activities | 0.0000 | USD | 1 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20240331 | Proceeds From Sale Maturity And Collections Of Investments | 73000000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20250331 | Retained Earnings Accumulated Deficit | -1992537000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001062822-25-000029 | 20250331 | Short Term Investments | 131951000.0000 | USD | 0 | us-gaap/2024 |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| tag | The unique identifier (name) for a tag in a specific taxonomy release. |
| version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
| ddate | The end date for the data value, rounded to the nearest month end. |
| qtrs | The count of the number of quarters represented by the data value, rounded to the nearest whole number. “0” indicates it is a point-in-time value. |
| uom | The unit of measure for the value. |
| segments | Tags used to represent axis and member reporting. |
| coreg | If specified, indicates a specific co-registrant, the parent company, or other entity (e.g., guarantor). NULL indicates the consolidated entity. |
| value | The value. This is not scaled, it is as found in the Interactive Data file, but is limited to four digits to the right of the decimal point. |
| footnote | The text of any superscripted footnotes on the value, as shown on the statement page, truncated to 512 characters, or if there is no footnote, then this field will be blank. |
| tag | version | custom | abstract | datatype | iord | crdr | tlabel | doc |
|---|---|---|---|---|---|---|---|---|
| Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period | us-gaap/2024 | 0 | 0 | shares | D | Share-Based Compensation Arrangement by Share-Based Payment Award, Shares Issued in Period | Number of shares issued under share-based payment arrangement. | |
| Increase Decrease In Accounts Receivable | us-gaap/2024 | 0 | 0 | monetary | D | C | Increase (Decrease) in Accounts Receivable | The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services. |
| Assets Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Assets, Current | Amount of asset recognized for present right to economic benefit, classified as current. |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | 0 | 0 | monetary | I | D | Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents | Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
| Revenue From Contract With Customer Excluding Assessed Tax | us-gaap/2024 | 0 | 0 | monetary | D | C | Revenue from Contract with Customer, Excluding Assessed Tax | Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise. |
| Stockholders Equity Including Portion Attributable To Noncontrolling Interest | us-gaap/2024 | 0 | 0 | monetary | I | C | Equity, Including Portion Attributable to Noncontrolling Interest | Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity. |
| Comprehensive Income Net Of Tax | us-gaap/2024 | 0 | 0 | monetary | D | C | Comprehensive Income (Loss), Net of Tax, Attributable to Parent | Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners. |
| Liabilities | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities | Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others. |
| Liabilities And Stockholders Equity | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities and Equity | Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any. |
| Retained Earnings Accumulated Deficit | us-gaap/2024 | 0 | 0 | monetary | I | C | Retained Earnings (Accumulated Deficit) | Amount of accumulated undistributed earnings (deficit). |
| Short Term Investments | us-gaap/2024 | 0 | 0 | monetary | I | D | Short-Term Investments | Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current. |
| Stock Issued During Period Value Share Based Compensation Gross | us-gaap/2024 | 0 | 0 | monetary | D | C | Shares Issued, Value, Share-Based Payment Arrangement, before Forfeiture | Value, before forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP). |
| Accounts Receivable Net Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Accounts Receivable, after Allowance for Credit Loss, Current | Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current. |
| Additional Paid In Capital | us-gaap/2024 | 0 | 0 | monetary | I | C | Additional Paid in Capital | Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock. |
| Adjustments Related To Tax Withholding For Share Based Compensation | us-gaap/2024 | 0 | 0 | monetary | D | D | Share-Based Payment Arrangement, Decrease for Tax Withholding Obligation | Amount of decrease to equity for grantee's tax withholding obligation for award under share-based payment arrangement. |
| Common Stock Par Or Stated Value Per Share | us-gaap/2024 | 0 | 0 | perShare | I | Common Stock, Par or Stated Value Per Share | Face amount or stated value per share of common stock. | |
| Net Income Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Net Income (Loss) Attributable to Parent | The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. |
| Payments To Acquire Investments | us-gaap/2024 | 0 | 0 | monetary | D | C | Payments to Acquire Investments | The cash outflow associated with the purchase of all investments (debt, security, other) during the period. |
| Stockholders Equity | us-gaap/2024 | 0 | 0 | monetary | I | C | Equity, Attributable to Parent | Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest. |
| Treasury Stock Value | us-gaap/2024 | 0 | 0 | monetary | I | D | Treasury Stock, Value | The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury. |
| Weighted Average Number Of Diluted Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | D | Weighted Average Number of Shares Outstanding, Diluted | The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. | |
| Accumulated Other Comprehensive Income Loss Net Of Tax | us-gaap/2024 | 0 | 0 | monetary | I | C | Accumulated Other Comprehensive Income (Loss), Net of Tax | Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source. |
| Assets | us-gaap/2024 | 0 | 0 | monetary | I | D | Assets | Amount of asset recognized for present right to economic benefit. |
| Common Stock Shares Issued | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares, Issued | Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. | |
| Cost Of Goods And Services Sold | us-gaap/2024 | 0 | 0 | monetary | D | D | Cost of Goods and Services Sold | The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities. |
| Earnings Per Share Diluted | us-gaap/2024 | 0 | 0 | perShare | D | Earnings Per Share, Diluted | The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. | |
| Operating Lease Right Of Use Asset | us-gaap/2024 | 0 | 0 | monetary | I | D | Operating Lease, Right-of-Use Asset | Amount of lessee's right to use underlying asset under operating lease. |
| Other Assets Noncurrent | us-gaap/2024 | 0 | 0 | monetary | I | D | Other Assets, Noncurrent | Amount of noncurrent assets classified as other. |
| Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options | us-gaap/2024 | 0 | 0 | monetary | D | D | Proceeds, Issuance of Shares, Share-Based Payment Arrangement, Including Option Exercised | Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised. |
| Accrued Liabilities Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Accrued Liabilities, Current | Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). |
| Depreciation Depletion And Amortization | us-gaap/2024 | 0 | 0 | monetary | D | D | Depreciation, Depletion and Amortization | The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets. |
| Increase Decrease In Other Operating Assets | us-gaap/2024 | 0 | 0 | monetary | D | C | Increase (Decrease) in Other Operating Assets | Amount of increase (decrease) in operating assets classified as other. |
| Liabilities Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities, Current | Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. |
| Other Expenses | us-gaap/2024 | 0 | 0 | monetary | D | D | Other Expenses | Amount of expense classified as other. |
| Preferred Stock Shares Issued | us-gaap/2024 | 0 | 0 | shares | I | Preferred Stock, Shares Issued | Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt. | |
| Selling General And Administrative Expense | us-gaap/2024 | 0 | 0 | monetary | D | D | Selling, General and Administrative Expense | The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc. |
| Share Based Compensation | us-gaap/2024 | 0 | 0 | monetary | D | D | Share-Based Payment Arrangement, Noncash Expense | Amount of noncash expense for share-based payment arrangement. |
| Amortization Of Financing Costs And Discounts | us-gaap/2024 | 0 | 0 | monetary | D | D | Amortization of Debt Issuance Costs and Discounts | Amount of amortization expense attributable to debt discount (premium) and debt issuance costs. |
| Cash And Cash Equivalents At Carrying Value | us-gaap/2024 | 0 | 0 | monetary | I | D | Cash and Cash Equivalents, at Carrying Value | Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. |
| Contract With Customer Liability | us-gaap/2024 | 0 | 0 | monetary | I | C | Contract with Customer, Liability | Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable. |
| Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction | us-gaap/2024 | 0 | 0 | monetary | D | D | Debt Issuance Costs Incurred During Noncash or Partial Noncash Transaction | The amount of debt issuance costs that were incurred during a noncash or partial noncash transaction. |
| Increase Decrease In Inventories | us-gaap/2024 | 0 | 0 | monetary | D | C | Increase (Decrease) in Inventories | The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities. |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | us-gaap/2024 | 0 | 0 | monetary | D | C | Increase (Decrease) in Prepaid Expense and Other Assets | Amount of increase (decrease) in prepaid expenses, and assets classified as other. |
| Preferred Stock Value | us-gaap/2024 | 0 | 0 | monetary | I | C | Preferred Stock, Value, Issued | Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity. |
| Other Noncash Income Expense | us-gaap/2024 | 0 | 0 | monetary | D | C | Other Noncash Income (Expense) | Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other. |
| Costs And Expenses | us-gaap/2024 | 0 | 0 | monetary | D | D | Costs and Expenses | Total costs of sales and operating expenses for the period. |
| Goodwill | us-gaap/2024 | 0 | 0 | monetary | I | D | Goodwill | Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized. |
| Net Cash Provided By Used In Operating Activities | us-gaap/2024 | 0 | 0 | monetary | D | Net Cash Provided by (Used in) Operating Activities | Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. | |
| Inventory Net | us-gaap/2024 | 0 | 0 | monetary | I | D | Inventory, Net | Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer. |
| Operating Income Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Operating Income (Loss) | The net result for the period of deducting operating expenses from operating revenues. |
| Other Assets Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Other Assets, Current | Amount of current assets classified as other. |
| Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax | us-gaap/2024 | 0 | 0 | monetary | D | C | OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax | Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale. |
| Other Liabilities Noncurrent | us-gaap/2024 | 0 | 0 | monetary | I | C | Other Liabilities, Noncurrent | Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer. |
| Proceeds From Issuance Of Convertible Preferred Stock | us-gaap/2024 | 0 | 0 | monetary | D | D | Proceeds from Issuance of Convertible Preferred Stock | The cash inflow from issuance of preferred stocks identified as being convertible into another form of financial instrument, typically the entity's common stock. |
| Proceeds From Payments For Other Financing Activities | us-gaap/2024 | 0 | 0 | monetary | D | D | Proceeds from (Payments for) Other Financing Activities | Amount of cash inflow (outflow) from financing activities classified as other. |
| Common Stock Value | us-gaap/2024 | 0 | 0 | monetary | I | C | Common Stock, Value, Issued | Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity. |
| Research And Development Expense | us-gaap/2024 | 0 | 0 | monetary | D | D | Research and Development Expense | Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. |
| Revenues | us-gaap/2024 | 0 | 0 | monetary | D | C | Revenues | Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). |
| Royalty Income Nonoperating | us-gaap/2024 | 0 | 0 | monetary | D | C | Royalty Income, Nonoperating | Ancillary revenue earned during the period from the consideration paid to the entity for the use of its rights and property by another party. Examples include licensing the use of copyrighted materials and leasing the extraction of natural resources. |
| Stock Issued During Period Shares New Issues | us-gaap/2024 | 0 | 0 | shares | D | Stock Issued During Period, Shares, New Issues | Number of new stock issued during the period. | |
| Accounts Payable Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Accounts Payable, Current | Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | us-gaap/2024 | 0 | 0 | monetary | D | D | Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
| Commitments And Contingencies | us-gaap/2024 | 0 | 0 | monetary | I | C | Commitments and Contingencies | Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur. |
| Common Stock Shares Authorized | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares Authorized | The maximum number of common shares permitted to be issued by an entity's charter and bylaws. | |
| Interest Paid Net | us-gaap/2024 | 0 | 0 | monetary | D | C | Interest Paid, Excluding Capitalized Interest, Operating Activities | Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount. |
| Net Cash Provided By Used In Financing Activities | us-gaap/2024 | 0 | 0 | monetary | D | D | Net Cash Provided by (Used in) Financing Activities | Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit. |
| Payments Related To Tax Withholding For Share Based Compensation | us-gaap/2024 | 0 | 0 | monetary | D | C | Payment, Tax Withholding, Share-Based Payment Arrangement | Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement. |
| Preferred Stock Par Or Stated Value Per Share | us-gaap/2024 | 0 | 0 | perShare | I | Preferred Stock, Par or Stated Value Per Share | Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer. | |
| Accretion Amortization Of Discounts And Premiums Investments | us-gaap/2024 | 0 | 0 | monetary | D | C | Accretion (Amortization) of Discounts and Premiums, Investments | The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method. |
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | us-gaap/2024 | 0 | 0 | monetary | D | C | APIC, Share-Based Payment Arrangement, Increase for Cost Recognition | Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement. |
| Earnings Per Share Basic | us-gaap/2024 | 0 | 0 | perShare | D | Earnings Per Share, Basic | The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. | |
| Increase Decrease In Accounts Payable And Accrued Liabilities | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Accounts Payable and Accrued Liabilities | The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid. |
| Net Cash Provided By Used In Investing Activities | us-gaap/2024 | 0 | 0 | monetary | D | D | Net Cash Provided by (Used in) Investing Activities | Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets. |
| Other Nonoperating Income Expense | us-gaap/2024 | 0 | 0 | monetary | D | C | Other Nonoperating Income (Expense) | Amount of income (expense) related to nonoperating activities, classified as other. |
| Preferred Stock Shares Authorized | us-gaap/2024 | 0 | 0 | shares | I | Preferred Stock, Shares Authorized | The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws. | |
| Preferred Stock Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | I | Preferred Stock, Shares Outstanding | Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased. | |
| Stock Issued During Period Value New Issues | us-gaap/2024 | 0 | 0 | monetary | D | C | Stock Issued During Period, Value, New Issues | Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering. |
| Long Term Debt Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Long-Term Debt, Current Maturities | Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as current. Excludes lease obligation. |
| Long Term Debt Noncurrent | us-gaap/2024 | 0 | 0 | monetary | I | C | Long-Term Debt, Excluding Current Maturities | Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation. |
| Proceeds From Sale Maturity And Collections Of Investments | us-gaap/2024 | 0 | 0 | monetary | D | D | Proceeds from Sale, Maturity and Collection of Investments | The cash inflow associated with the sale, maturity and collection of all investments such as debt, security and so forth during the period. |
| Property Plant And Equipment Net | us-gaap/2024 | 0 | 0 | monetary | I | D | Property, Plant and Equipment, Net | Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures. |
| Treasury Stock Common Shares | us-gaap/2024 | 0 | 0 | shares | I | Treasury Stock, Common, Shares | Number of previously issued common shares repurchased by the issuing entity and held in treasury. | |
| Weighted Average Number Of Shares Outstanding Basic | us-gaap/2024 | 0 | 0 | shares | D | Weighted Average Number of Shares Outstanding, Basic | Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. |
| Field Name | Field Description |
|---|---|
| tag | The unique identifier (name) for a tag in a specific taxonomy release. |
| version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
| custom | 1 if tag is custom (version=adsh), 0 if it is standard. Note: This flag is technically redundant with the version and adsh columns. |
| abstract | 1 if the tag is not used to represent a numeric fact. |
| datatype | If abstract=1, then NULL, otherwise the data type (e.g., monetary) for the tag. |
| iord | If abstract=1, then NULL; otherwise, “I” if the value is a point-in time, or “D” if the value is a duration. |
| crdr | If datatype = monetary, then the tag’s natural accounting balance (debit or credit); if not defined, then NULL. |
| tlabel | If a standard tag, then the label text provided by the taxonomy, otherwise the text provided by the filer. A tag which had neither would have a NULL value here. |
| doc | The detailed definition for the tag. If a standard tag, then the text provided by the taxonomy, otherwise the text assigned by the filer. Some tags have neither, and this field is NULL. |
| adsh | report | line | stmt | inpth | rfile | tag | version | plabel | negating |
|---|---|---|---|---|---|---|---|---|---|
| 0001062822-25-000029 | 2 | 3 | BS | 0 | H | Cash And Cash Equivalents At Carrying Value | us-gaap/2024 | Cash and cash equivalents | 0 |
| 0001062822-25-000029 | 2 | 4 | BS | 0 | H | Short Term Investments | us-gaap/2024 | Short-term investments | 0 |
| 0001062822-25-000029 | 2 | 5 | BS | 0 | H | Accounts Receivable Net Current | us-gaap/2024 | Accounts receivable, net | 0 |
| 0001062822-25-000029 | 2 | 6 | BS | 0 | H | Inventory Net | us-gaap/2024 | Inventory | 0 |
| 0001062822-25-000029 | 2 | 7 | BS | 0 | H | Other Assets Current | us-gaap/2024 | Prepaid expenses and other current assets | 0 |
| 0001062822-25-000029 | 2 | 8 | BS | 0 | H | Assets Current | us-gaap/2024 | Total current assets | 0 |
| 0001062822-25-000029 | 2 | 9 | BS | 0 | H | Property Plant And Equipment Net | us-gaap/2024 | Property and equipment, net | 0 |
| 0001062822-25-000029 | 2 | 10 | BS | 0 | H | Goodwill | us-gaap/2024 | Goodwill | 0 |
| 0001062822-25-000029 | 2 | 11 | BS | 0 | H | Operating Lease Right Of Use Asset | us-gaap/2024 | Operating lease right-of-use-assets | 0 |
| 0001062822-25-000029 | 2 | 12 | BS | 0 | H | Other Assets Noncurrent | us-gaap/2024 | Other assets | 0 |
| 0001062822-25-000029 | 2 | 13 | BS | 0 | H | Assets | us-gaap/2024 | Total assets | 0 |
| 0001062822-25-000029 | 2 | 16 | BS | 0 | H | Accounts Payable Current | us-gaap/2024 | Accounts payable | 0 |
| 0001062822-25-000029 | 2 | 17 | BS | 0 | H | Accrued Liabilities Current | us-gaap/2024 | Accrued liabilities | 0 |
| 0001062822-25-000029 | 2 | 18 | BS | 0 | H | Contract With Customer Liability | us-gaap/2024 | Deferred revenue | 0 |
| 0001062822-25-000029 | 2 | 19 | BS | 0 | H | Long Term Debt Current | us-gaap/2024 | Current portion of long-term debt | 0 |
| 0001062822-25-000029 | 2 | 20 | BS | 0 | H | Liabilities Current | us-gaap/2024 | Total current liabilities | 0 |
| 0001062822-25-000029 | 2 | 21 | BS | 0 | H | Long Term Debt Noncurrent | us-gaap/2024 | Long-term debt, net | 0 |
| 0001062822-25-000029 | 2 | 22 | BS | 0 | H | Other Liabilities Noncurrent | us-gaap/2024 | Other long-term liabilities | 0 |
| 0001062822-25-000029 | 2 | 23 | BS | 0 | H | Liabilities | us-gaap/2024 | Total liabilities | 0 |
| 0001062822-25-000029 | 2 | 24 | BS | 0 | H | Commitments And Contingencies | us-gaap/2024 | Commitments and contingencies (Note 7) | 0 |
| 0001062822-25-000029 | 2 | 26 | BS | 0 | H | Preferred Stock Value | us-gaap/2024 | Series A Convertible preferred stock; 2,304,147 shares issued and none outstanding at March 31, 2025 and December 31, 2024 | 0 |
| 0001062822-25-000029 | 2 | 27 | BS | 0 | H | Common Stock Value | us-gaap/2024 | Common stock, $0.001 par value; 450,000,000 shares authorized; 365,559,939 and 363,020,303 shares issued, respectively | 0 |
| 0001062822-25-000029 | 2 | 28 | BS | 0 | H | Additional Paid In Capital | us-gaap/2024 | Additional paid-in capital | 0 |
| 0001062822-25-000029 | 2 | 29 | BS | 0 | H | Retained Earnings Accumulated Deficit | us-gaap/2024 | Accumulated deficit | 0 |
| 0001062822-25-000029 | 2 | 30 | BS | 0 | H | Accumulated Other Comprehensive Income Loss Net Of Tax | us-gaap/2024 | Accumulated other comprehensive income | 0 |
| 0001062822-25-000029 | 2 | 31 | BS | 0 | H | Treasury Stock Value | us-gaap/2024 | Treasury stock, at cost, 2,381,939 and 1,528,008 shares, respectively | 1 |
| 0001062822-25-000029 | 2 | 32 | BS | 0 | H | Stockholders Equity | us-gaap/2024 | Total stockholders equity | 0 |
| 0001062822-25-000029 | 2 | 33 | BS | 0 | H | Liabilities And Stockholders Equity | us-gaap/2024 | Total liabilities and stockholders equity | 0 |
| 0001062822-25-000029 | 2 | 34 | BS | 0 | H | Preferred Stock Shares Issued | us-gaap/2024 | Preferred stock, issued (in shares) | 0 |
| 0001062822-25-000029 | 2 | 35 | BS | 0 | H | Preferred Stock Shares Outstanding | us-gaap/2024 | Preferred stock, outstanding (in shares) | 0 |
| 0001062822-25-000029 | 3 | 1 | BS | 1 | H | Preferred Stock Par Or Stated Value Per Share | us-gaap/2024 | Preferred stock, par value (in dollars per share) | 0 |
| 0001062822-25-000029 | 3 | 2 | BS | 1 | H | Preferred Stock Shares Authorized | us-gaap/2024 | Preferred stock, authorized (in shares) | 0 |
| 0001062822-25-000029 | 3 | 3 | BS | 1 | H | Preferred Stock Shares Outstanding | us-gaap/2024 | Preferred stock, outstanding (in shares) | 0 |
| 0001062822-25-000029 | 3 | 4 | BS | 1 | H | Preferred Stock Shares Issued | us-gaap/2024 | Preferred stock, issued (in shares) | 0 |
| 0001062822-25-000029 | 3 | 5 | BS | 1 | H | Common Stock Par Or Stated Value Per Share | us-gaap/2024 | Common stock, par value (in dollars per share) | 0 |
| 0001062822-25-000029 | 3 | 6 | BS | 1 | H | Common Stock Shares Authorized | us-gaap/2024 | Common stock, authorized (in shares) | 0 |
| 0001062822-25-000029 | 3 | 7 | BS | 1 | H | Common Stock Shares Issued | us-gaap/2024 | Common stock, issued (in shares) | 0 |
| 0001062822-25-000029 | 3 | 8 | BS | 1 | H | Treasury Stock Common Shares | us-gaap/2024 | Treasury stock (in shares) | 0 |
| 0001062822-25-000029 | 4 | 2 | IS | 0 | H | Revenue From Contract With Customer Excluding Assessed Tax | us-gaap/2024 | Net product revenue | 0 |
| 0001062822-25-000029 | 4 | 3 | IS | 0 | H | Royalty Income Nonoperating | us-gaap/2024 | Royalties and other revenue | 0 |
| 0001062822-25-000029 | 4 | 4 | IS | 0 | H | Revenues | us-gaap/2024 | Total revenues | 0 |
| 0001062822-25-000029 | 4 | 6 | IS | 0 | H | Cost Of Goods And Services Sold | us-gaap/2024 | Cost of sales | 0 |
| 0001062822-25-000029 | 4 | 7 | IS | 0 | H | Research And Development Expense | us-gaap/2024 | Research and development | 0 |
| 0001062822-25-000029 | 4 | 8 | IS | 0 | H | Selling General And Administrative Expense | us-gaap/2024 | Selling, general and administrative, including stock-based compensation of $1,469 and $2,708, respectively | 0 |
| 0001062822-25-000029 | 4 | 9 | IS | 0 | H | Costs And Expenses | us-gaap/2024 | Total operating expenses | 0 |
| 0001062822-25-000029 | 4 | 10 | IS | 0 | H | Operating Income Loss | us-gaap/2024 | Loss from operations | 0 |
| 0001062822-25-000029 | 4 | 11 | IS | 0 | H | Other Expenses | us-gaap/2024 | Interest and other expense | 1 |
| 0001062822-25-000029 | 4 | 12 | IS | 0 | H | Other Nonoperating Income Expense | us-gaap/2024 | Interest income and other, net | 0 |
| 0001062822-25-000029 | 4 | 13 | IS | 0 | H | Net Income Loss | us-gaap/2024 | Net loss | 0 |
| 0001062822-25-000029 | 4 | 14 | IS | 0 | H | Earnings Per Share Basic | us-gaap/2024 | Net loss per common share, basic (usd per share) | 0 |
| 0001062822-25-000029 | 4 | 15 | IS | 0 | H | Earnings Per Share Diluted | us-gaap/2024 | Net loss per common share, diluted (usd per share) | 0 |
| 0001062822-25-000029 | 4 | 16 | IS | 0 | H | Weighted Average Number Of Shares Outstanding Basic | us-gaap/2024 | Shares used in computing net loss per common share, basic | 0 |
| 0001062822-25-000029 | 4 | 17 | IS | 0 | H | Weighted Average Number Of Diluted Shares Outstanding | us-gaap/2024 | Shares used in computing net loss per common share, diluted | 0 |
| 0001062822-25-000029 | 4 | 19 | IS | 0 | H | Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax | us-gaap/2024 | Unrealized loss on investments | 0 |
| 0001062822-25-000029 | 4 | 20 | IS | 0 | H | Comprehensive Income Net Of Tax | us-gaap/2024 | Comprehensive loss | 0 |
| 0001062822-25-000029 | 5 | 7 | IS | 1 | H | Share Based Compensation | us-gaap/2024 | Stock-based compensation | 0 |
| 0001062822-25-000029 | 6 | 11 | EQ | 0 | H | Common Stock Shares Issued | us-gaap/2024 | Common stock beginning balance (in shares) | 0 |
| 0001062822-25-000029 | 6 | 12 | EQ | 0 | H | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | us-gaap/2024 | Beginning balance | 0 |
| 0001062822-25-000029 | 6 | 13 | EQ | 0 | H | Preferred Stock Shares Issued | us-gaap/2024 | Preferred stock beginning balance (in shares) | 0 |
| 0001062822-25-000029 | 6 | 14 | EQ | 0 | H | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | us-gaap/2024 | Stock-based compensation | 0 |
| 0001062822-25-000029 | 6 | 15 | EQ | 0 | H | Stock Issued During Period Shares New Issues | us-gaap/2024 | Stock Issued During Period, Shares, New Issues | 0 |
| 0001062822-25-000029 | 6 | 16 | EQ | 0 | H | Stock Issued During Period Value New Issues | us-gaap/2024 | Stock Issued During Period, Value, New Issues | 0 |
| 0001062822-25-000029 | 6 | 17 | EQ | 0 | H | Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period | us-gaap/2024 | Issuance of common stock under Equity Incentive Plans (in shares) | 0 |
| 0001062822-25-000029 | 6 | 18 | EQ | 0 | H | Stock Issued During Period Value Share Based Compensation Gross | us-gaap/2024 | Issuance of common stock under Equity Incentive Plans | 0 |
| 0001062822-25-000029 | 6 | 19 | EQ | 0 | H | Net Income Loss | us-gaap/2024 | Net loss | 0 |
| 0001062822-25-000029 | 6 | 20 | EQ | 0 | H | Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax | us-gaap/2024 | Unrealized loss on investments | 0 |
| 0001062822-25-000029 | 6 | 21 | EQ | 0 | H | Common Stock Shares Issued | us-gaap/2024 | Common stock ending balance (in shares) | 0 |
| 0001062822-25-000029 | 6 | 22 | EQ | 0 | H | Stockholders Equity Including Portion Attributable To Noncontrolling Interest | us-gaap/2024 | Ending balance | 0 |
| 0001062822-25-000029 | 6 | 23 | EQ | 0 | H | Preferred Stock Shares Issued | us-gaap/2024 | Preferred stock ending balance (in shares) | 0 |
| 0001062822-25-000029 | 6 | 24 | EQ | 0 | H | Adjustments Related To Tax Withholding For Share Based Compensation | us-gaap/2024 | Payments for tax withholding on share-based compensation vesting | 1 |
| 0001062822-25-000029 | 7 | 2 | CF | 0 | H | Net Income Loss | us-gaap/2024 | Net loss | 0 |
| 0001062822-25-000029 | 7 | 4 | CF | 0 | H | Depreciation Depletion And Amortization | us-gaap/2024 | Depreciation and amortization | 0 |
| 0001062822-25-000029 | 7 | 5 | CF | 0 | H | Share Based Compensation | us-gaap/2024 | Stock-based compensation | 0 |
| 0001062822-25-000029 | 7 | 6 | CF | 0 | H | Amortization Of Financing Costs And Discounts | us-gaap/2024 | Amortization/accretion of debt-related costs | 0 |
| 0001062822-25-000029 | 7 | 7 | CF | 0 | H | Accretion Amortization Of Discounts And Premiums Investments | us-gaap/2024 | Accretion of marketable securities purchased at a discount | 1 |
| 0001062822-25-000029 | 7 | 8 | CF | 0 | H | Other Noncash Income Expense | us-gaap/2024 | Other non-cash adjustments | 1 |
| 0001062822-25-000029 | 7 | 10 | CF | 0 | H | Increase Decrease In Accounts Receivable | us-gaap/2024 | Decrease (increase) in accounts receivable | 1 |
| 0001062822-25-000029 | 7 | 11 | CF | 0 | H | Increase Decrease In Inventories | us-gaap/2024 | Decrease (increase) in inventories | 1 |
| 0001062822-25-000029 | 7 | 12 | CF | 0 | H | Increase Decrease In Prepaid Deferred Expense And Other Assets | us-gaap/2024 | Decrease (increase) in prepaid expenses and other current assets | 1 |
| 0001062822-25-000029 | 7 | 13 | CF | 0 | H | Increase Decrease In Other Operating Assets | us-gaap/2024 | Decrease in other long-term assets | 1 |
| 0001062822-25-000029 | 7 | 14 | CF | 0 | H | Increase Decrease In Accounts Payable And Accrued Liabilities | us-gaap/2024 | Decrease in accounts payable and other liabilities | 0 |
| 0001062822-25-000029 | 7 | 15 | CF | 0 | H | Net Cash Provided By Used In Operating Activities | us-gaap/2024 | Net cash used in operating activities | 0 |
| 0001062822-25-000029 | 7 | 17 | CF | 0 | H | Payments To Acquire Investments | us-gaap/2024 | Purchases of investments | 1 |
| 0001062822-25-000029 | 7 | 18 | CF | 0 | H | Proceeds From Sale Maturity And Collections Of Investments | us-gaap/2024 | Maturities of investments | 0 |
| 0001062822-25-000029 | 7 | 19 | CF | 0 | H | Net Cash Provided By Used In Investing Activities | us-gaap/2024 | Net cash provided by (used in) investing activities | 0 |
| 0001062822-25-000029 | 7 | 21 | CF | 0 | H | Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options | us-gaap/2024 | Proceeds from issuance of common stock for equity incentive plans | 0 |
| 0001062822-25-000029 | 7 | 22 | CF | 0 | H | Proceeds From Issuance Of Convertible Preferred Stock | us-gaap/2024 | Proceeds from issuance of preferred stock, net of fees | 0 |
| 0001062822-25-000029 | 7 | 23 | CF | 0 | H | Payments Related To Tax Withholding For Share Based Compensation | us-gaap/2024 | Payments for tax withholding on share-based compensation vesting | 0 |
| 0001062822-25-000029 | 7 | 24 | CF | 0 | H | Proceeds From Payments For Other Financing Activities | us-gaap/2024 | Other debt financing fees | 0 |
| 0001062822-25-000029 | 7 | 25 | CF | 0 | H | Net Cash Provided By Used In Financing Activities | us-gaap/2024 | Net cash (used in) provided by financing activities | 0 |
| 0001062822-25-000029 | 7 | 26 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | us-gaap/2024 | Net (decrease) increase in cash and cash equivalents | 0 |
| 0001062822-25-000029 | 7 | 27 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | Cash and cash equivalents at beginning of period | 0 |
| 0001062822-25-000029 | 7 | 28 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | Cash and cash equivalents at end of period | 0 |
| 0001062822-25-000029 | 7 | 30 | CF | 0 | H | Interest Paid Net | us-gaap/2024 | Cash paid for interest | 0 |
| 0001062822-25-000029 | 7 | 32 | CF | 0 | H | Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction | us-gaap/2024 | Accrued financing costs | 0 |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| report | Represents the report grouping. This field corresponds to the statement (stmt) field, which indicates the type of statement. The numeric value refers to the “R file” as posted on the EDGAR Web site. |
| line | Represents the tag’s presentation line order for a given report. Together with the statement and report field, presentation location, order and grouping can be derived. |
| stmt | The financial statement location to which the value of the “report” field pertains. |
| inpth | Value was presented “parenthetically” instead of in columns within the financial statements. For example: Receivables (net of allowance for bad debts of $200 in 2012) $700. |
| rfile | The type of interactive data file rendered on the EDGAR web site, H = .htm file, X = .xml file. |
| tag | The tag chosen by the filer for this line item. |
| version | The taxonomy identifier if the tag is a standard tag, otherwise adsh. |
| plabel | The text presented on the line item, also known as a “preferred” label. |
| negating | Flag to indicate whether the plabel is negating. |